OUR STORY SO FAR
CanniOasis: Personalized cannabinoid-based biopharma company from Singapore
Founded in 2021, CanniOasis has created a theragnostic platform for the development of precision cannabinoid-based drugs that includes state-of-the-art prognostic clinical testing and molecular mapping to guide the personalized treatment of neurological disorders. A key differentiator and competitive advantage for the Company is its midbrain organoid model that will substantially de-risk and shorten the drug development process for neurological disorders.
Advisory Team
Our Expert Advisors
Prof. Moshe Szyf
Scientific Advisor
Professor of Pharmacology and fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences
Experience in diagnostics and therapeutics and founded the first Pharma in the world dedicated to DNA methylation drugs
Prof. Hyman Schipper
Scientific / Medical Advisor
MD and PHD (Neuroendocrinology)
Founding Director and scientist for Centre for Neurotranslational Research and Molecular Biometrics Inc
Expert in oxidative stress, brain aging and neurodegenerative diseases
Prof. Peter Lim
Independent Director
Medical Director of Andrology, Urology & Continence (Gleneagles H)
Professor at Cowen University, Australia and Honorary Professor at HT Naval Medical School, Indonesia
Novanne Seah
Co-Founder / Director
Accomplished professional with expertise in nutri-pharmaceuticals and biomedicine
Director of several biotech companies incl. Gene Oasis, Zenzic Labs and Green Oasis Therapeutics
Chairman of ER Therapeutics, a listed company in China focusing on Endoplasmic Reticulum Biomedicine
The Management Team
Our awesome team members
Dr Lim Kah Meng
Founder / Non-Executive Chairman / Chief Scientific Advisor
Experienced scientist in the biotechnology and biopharmaceutical industry
Started his career as a Research Scientist in A*Star and as a Professor in NTU before venturing as an entrepreneur and advisor to several biotech companies
Currently serving as Independent Director in a SGX listed company and Board director in several other biotech companies
Holds Ph.D. in Biomedicine from National University of Singapore
Dr Tan Jok Tin
Vice Chairman
More than 40 years of senior executive experience incl. Chairman of Creative Technology Ltd, Vice Chairman of China-Asia Economic Development Association, ex CEO of Singapore WTC, Royal Philips Electronics, China Electronics Corporations etc
Senior Advisor and independent director of China-Singapore Guangzhou Knowledge City and Susing Asset Management (China)
Jon Lim
CEO / Director
More than 20 years performing finance and business strategy in KLA, Agilent Technologies, Merrill Lynch, OCBC and HL Display, in the USA, Sweden, Germany, Switzerland, and the Asia Pacific region.
Served as a Professional Management Consultant (PMC) and a consultant of Intellectual Property Office of Singapore (IPOS)
Joshua Siow
CFO
More than 30 years of senior executive and board membership with exchange listed on TSX, Stock exchange Thailand and SGX
CA, CIA and CRM with a MBA
ISO 9000 Lead Auditor and is a member of Singapore Institute of Directors
Treasurer and Chair the Finance Committee at 365 Cancer Prevention Society
Alfred Tan
COO / Director
More than 20 years of experience in marketing, operations, training and consultancy in the health and wellness, lifestyle and E commerce industries
MBA and is a Certified Certified AGILE Practioner
Singapore Certified Management Consultant (SCMC)
Dr Ron Tan
Executive Scientific Partner
More than 17 years experience in clinical diagnostics innovation
OUR PARTNERS
We partner with leading institutions
We partner with companies of all sizes to make a difference in our field.
A*Star
Singapore's lead public sector agency that spearheads economic oriented research to advance scientific discovery and develop innovative technology
Learn MoreGene Oasis
Gene Oasis is a business group registered in Singapore specializing in the production of natural bioactive ingredients, innovative products and efficient delivery systems based on a strong portfolio of proprietary technologies/intellectual properties (IPs)
Learn MoreWuXi AppTec
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients.
Learn More